We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.83%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
+$2.18B
(+5%)
Cap. Flow
+$425M
Cap. Flow
% of AUM
0.92%
Top 10 Holdings %
Top 10 Hldgs %
15.17%
Holding
2,954
New
28
Increased
2,252
Reduced
604
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$128M |
| 2 |
Baker Hughes
BKR
|
+$26.7M |
| 3 |
IQVIA
IQV
|
+$14.5M |
| 4 |
Oneok
OKE
|
+$14.3M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$11.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$114M |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$88.6M |
| 3 |
BHI
Baker Hughes
BHI
|
+$41.6M |
| 4 |
WFM
Whole Foods Market Inc
WFM
|
+$26.7M |
| 5 |
UnitedHealth
UNH
|
+$22.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.64% |
| 2 | Technology | 15.8% |
| 3 | Healthcare | 13.57% |
| 4 | Industrials | 10.87% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OPB
2026
DELISTED
Opus Bank Common Stock
OPB
| $897K | ﹤0.01% |
37,384
+630
| +2% | +$14.6K |
|
2027
Preferred Bank
PFBC
$1.24B
| $894K | ﹤0.01% |
14,815
+200
| +1% | +$11K |
|
2028
Mercado Libre
MELI
$95.2B
| $893K | ﹤0.01% |
3,449
+809
| +31% | +$214K |
|
2029
Enova International
ENVA
$6.33B
| $892K | ﹤0.01% |
66,351
+9,405
| +17% | +$128K |
|
2030
ANI Pharmaceuticals
ANIP
$1.8B
| $891K | ﹤0.01% |
16,982
+990
| +6% | +$47.2K |
|
|
MYOK
2031
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $891K | ﹤0.01% |
20,788
+2,299
| +12% | +$73.3K |
|
2032
Varonis Systems
VRNS
$4.59B
| $889K | ﹤0.01% |
63,684
+870
| +1% | +$11.2K |
|
2033
Movado Group
MOV
$849M
| $886K | ﹤0.01% |
31,637
+580
| +2% | +$14.7K |
|
|
BMTC
2034
DELISTED
Bryn Mawr Bank Corp
BMTC
| $883K | ﹤0.01% |
20,159
+120
| +0.6% | +$5K |
|
|
ASNA
2035
DELISTED
Ascena Retail Group, Inc.
ASNA
| $883K | ﹤0.01% |
18,028
+521
| +3% | +$22.6K |
|
2036
Akebia Therapeutics
AKBA
$354M
| $881K | ﹤0.01% |
44,765
+3,255
| +8% | +$50K |
|
2037
MGP Ingredients
MGPI
$379M
| $880K | ﹤0.01% |
14,522
+200
| +1% | +$11.5K |
|
|
SNCR
2038
DELISTED
Synchronoss Technologies
SNCR
| $880K | ﹤0.01% |
10,480
+181
| +2% | +$25.2K |
|
|
GLOG
2039
DELISTED
GASLOG LTD
GLOG
| $879K | ﹤0.01% |
50,365
+220
| +0.4% | +$3.69K |
|
2040
Casella Waste Systems
CWST
$5.71B
| $877K | ﹤0.01% |
46,642
+415
| +0.9% | +$7.07K |
|
|
ESIO
2041
DELISTED
Electro Scientific Industries
ESIO
| $877K | ﹤0.01% |
63,009
+1,140
| +2% | +$12.3K |
|
|
ALDR
2042
DELISTED
Alder Biopharmaceuticals
ALDR
| $874K | ﹤0.01% |
71,334
+9,918
| +16% | +$103K |
|
2043
NN Inc
NNBR
$255M
| $873K | ﹤0.01% |
30,103
+430
| +1% | +$11.7K |
|
|
SYNT
2044
DELISTED
Syntel Inc
SYNT
| $873K | ﹤0.01% |
44,405
+525
| +1% | +$9.58K |
|
2045
SandRidge Energy
SD
$514M
| $867K | ﹤0.01% |
43,150
+449
| +1% | +$8.32K |
|
|
WIFI
2046
DELISTED
Boingo Wireless, Inc.
WIFI
| $859K | ﹤0.01% |
40,201
+570
| +1% | +$10.5K |
|
2047
Federal Agricultural Mortgage
AGM
$2.47B
| $856K | ﹤0.01% |
11,769
+130
| +1% | +$8.78K |
|
|
FMSA
2048
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $856K | ﹤0.01% |
179,013
+1,469
| +0.8% | +$4.75K |
|
|
SRDX
2049
DELISTED
Surmodics
SRDX
| $854K | ﹤0.01% |
27,553
+555
| +2% | +$15.1K |
|
|
MCRN
2050
DELISTED
Milacron Holdings Corp.
MCRN
| $853K | ﹤0.01% |
50,602
+1,985
| +4% | +$33.7K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2017 Portfolio in Review
As of Q3 2017, RhumbLine Advisers held 2,954 positions worth $46B, up 5% from $43.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q3 2017: portfolio turnover was 2.6%. RhumbLine Advisers opened 28 new positions and exited 50, leaving the 2,954-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q3 2017 buy was Baker Hughes: 750,985 shares worth $27.5M.
- RhumbLine Advisers added most to DuPont de Nemours in Q3 2017, an estimated $128M increase.
- RhumbLine Advisers's biggest Q3 2017 reduction was UnitedHealth, cutting an estimated $22.8M.
- RhumbLine Advisers fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $114M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $46B portfolio in Q3 2017.
- RhumbLine Advisers opened 28 new positions and closed 50 in Q3 2017.
- RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q3 2017, filed 6 Nov 2017.